Edlund Mark J, Sullivan Mark, Steffick Diane, Harris Katherine M, Wells Kenneth B
Central Arkansas Veterans Healthcare System, North Little Rock, Arkansas, USA.
Pain Med. 2007 Nov-Dec;8(8):647-56. doi: 10.1111/j.1526-4637.2006.00200.x.
To determine whether individuals who use prescribed opioids for chronic noncancer pain have higher rates of any opioid misuse, any problem opioid misuse, nonopioid illicit drug use, nonopioid problem drug use, or any problem alcohol use, compared with those who do not use prescribed opioids.
Respondents were from a nationally representative survey (N = 9,279), which contained measures of regular use of prescribed opioids, substance use problems, mental health disorders, physical health, pain, and sociodemographics.
In unadjusted models, compared with nonusers of prescription opioids, users of prescription opioids had significantly higher rates of any opioid misuse (odds ratio [OR] = 5.48, P < 0.001), problem opioid misuse (OR = 14.76, P < 0.001), nonopioid illicit drug use (OR = 1.73, P < 0.01), nonopioid problem drug use (OR = 4.48, P < 0.001), and problem alcohol use (OR = 1.89, P = 0.04). In adjusted models, users of prescribed opioids had significantly higher rates of any opioid misuse (OR = 3.07, P < 0.001) and problem opioid misuse (OR = 6.11, P < 0.001) but did not have significantly higher rates of the other outcomes.
Users of prescribed opioids had higher rates of opioid and nonopioid abuse problems compared with nonusers of prescribed opioids, but these higher rates appear to be partially mediated by depressive and anxiety disorders. It is not possible to assign causal priority based on our cross-sectional data, but our findings are more compatible with mental disorders leading to substance abuse among prescription opioid users than prescription opioids themselves prompting substance abuse iatrogenically. In patients receiving prescribed opioids, clinicians need to be alert to drug abuse problems and potentially mediating mental health disorders.
确定与未使用处方阿片类药物的个体相比,使用处方阿片类药物治疗慢性非癌性疼痛的个体出现任何阿片类药物滥用、任何问题性阿片类药物滥用、非阿片类非法药物使用、非阿片类问题药物使用或任何问题性酒精使用的比率是否更高。
受访者来自一项具有全国代表性的调查(N = 9279),该调查包含了定期使用处方阿片类药物、物质使用问题、心理健康障碍、身体健康、疼痛和社会人口统计学的测量指标。
在未调整的模型中,与未使用处方阿片类药物的人相比,使用处方阿片类药物的人出现任何阿片类药物滥用(优势比[OR] = 5.48,P < 0.001)、问题性阿片类药物滥用(OR = 14.76,P < 0.001)、非阿片类非法药物使用(OR = 1.73,P < 0.01)、非阿片类问题药物使用(OR = 4.48,P < 0.001)和问题性酒精使用(OR = 1.89,P = 0.04)的比率显著更高。在调整后的模型中,使用处方阿片类药物的人出现任何阿片类药物滥用(OR = 3.07,P < 0.001)和问题性阿片类药物滥用(OR = 6.11,P < 0.001)的比率显著更高,但其他结果的比率没有显著升高。
与未使用处方阿片类药物的人相比,使用处方阿片类药物的人出现阿片类和非阿片类药物滥用问题的比率更高,但这些较高的比率似乎部分由抑郁和焦虑障碍介导。基于我们的横断面数据无法确定因果优先级,但我们的研究结果更符合精神障碍导致处方阿片类药物使用者出现物质滥用,而不是处方阿片类药物本身医源性地促使物质滥用。在接受处方阿片类药物治疗的患者中,临床医生需要警惕药物滥用问题以及潜在的介导心理健康障碍。